Navy was running trial for new test for flu in San Diego found first 2 cases

Q. How did these swine flu cases end up at NHRC?

The first case, a 10-year-old DOD dependent, was identified in a trial to evaluate a novel influenza diagnostic. On 1 April, a swab sample from the patient was tested on the diagnostic platform.
Read more
Behind the Scenes: Navy Researchers Helped Spot Swine Flu in the United States
http://blogs.sciencemag.org/scienceinsider/2009/04/behind-th...

Then just in time to "take advantage of a crisis" one biopharmaceutical company working with NHRC Gets FDA approval for flu test:

Arbor Vita Receives FDA Clearance of its AVantage™ A/H5N1 Flu Diagnostic
First Rapid Test for Avian Influenza in Humans
http://www.arborvita.com/news_PR13.html
Sunnyvale, CA—April 7, 2009—Arbor Vita Corporation (AVC), a biopharmaceutical company developing both diagnostics and therapeutics, announced that it has received 510(k) clearance from the U.S. Food and Drug Administration for its AVantage™ A/H5N1 Flu Test. This is a non-invasive rapid diagnostic device for the specific detection of the avian influenza A/H5N1 virus in humans. AVC's AVantage A/H5N1 Flu Test detects the influenza virus nonstructural protein 1 (NS1) in specimens from throat swabs or nose swabs collected from patients with flu symptoms.

The U.S. Navy was an integral partner in evaluating this flu test for FDA clearance, with the Naval Health Research Center (NHRC) in San Diego, CA providing testing on both archival and prospective clinical specimens to ensure the specificity of the test, while Navy Medical Research Unit-3 (NAMRU-3) provided invaluable access to avian influenza isolates for development and testing.

Gee drugs too! they do it all. Stay tuned to see who comes up with a cure for this.

Arbor Vita (www.arborvita.com) is a biopharmaceutical company pioneering the discovery, development and commercialization of novel drugs and diagnostics through a new family of targets—PDZ proteins. PDZ proteins are key cellular organizers in human signaling pathways. Recruited by viral pathogens, PDZ proteins are highly conserved and provide an ideal platform for identification of diagnostic markers for cancers, infectious diseases and other complex diseases. The company capitalizes on its unique mix of expertise, intellectual property, and novel PDZ drug discovery platform to accelerate discovery and development programs for both therapeutics and diagnostics. Arbor Vita's current programs address major health areas including complex diseases such as cervical cancer and stroke, as well as infectious diseases such as influenza.
____________________________________________
The Federal Reserve, Stealing the American Dream since 1913

Check out the videos I'm watching on YouTube
http://www.youtube.com/user/sharpsteve2003